UnitedHealth reported Q1 FY 2017 earnings of $2.37 per share (versus $1.81 in Q1 FY 2016), beating analysts' consensus estimate of $2.17.
The company's quarterly revenues amounted to $48.723 bln (+9.4% y/y), beating analysts' consensus estimate of $48.211 bln.
The company also sued raised guidance for FY 2017, projecting EPS of $9.65-9.85 (versus previously forecast $9.30-9.60 and analysts' consensus estimate of $9.51) and revenues of $200 bln (versus previously forecast $197-199 bln and analysts' consensus estimate of $198.94 bln).
UNH rose to $171.00 (+2.29%) in pre-market trading.